Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Opens in a new tab or window Just over half of patients with overweight or obesity discontinued their GLP-1 receptor ... of diabetes status, every 1% of body weight loss was tied to a 3% lower ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

At least 27 new GLP-1 drugs are currently undergoing trials ... this next generation of medications may offer even greater weight loss benefits than either semaglutide or tirzepatide alone.